Status:
COMPLETED
An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Neoplasms
Eligibility:
All Genders
16-30 years
Brief Summary
Background: * Few resources exist for helping adolescents and young adults with cancer or HIV disease understand their changing physical, emotional and social needs when treatment is no longer effect...
Detailed Description
Background: * Discussing end of life (EoL) care with adolescents and young adults can be one of the most difficult aspects of living with a life threatening disease. * Few established resources exist...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age: 16 to 30 years
- Patients at NIH or participating site must have 1) a diagnosis of metastatic, recurrent, or progressive cancer with a mean survival rate of 2 years or less or 2) a diagnosis of perinatal or early life transfusion associated HIV infection. The treatment protocol PI or attending physician must consent to have a patient entered into this protocol. Newly diagnosed patients must have completed at least three cycles of chemotherapy.
- For patients less than 18 years of age, a legal guardian must provide informed consent and the patients must sign an assent document.
- Patients greater than 18 years of age must give informed consent.
- Patients less than 18 years of age must have a score of 40 or higher on Lanksy/Karnofsky, as determined by the medical team at the time of enrollment.
- Patients greater than 18 years of age must have a score of 3 or less on the Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS) at the time of enrollment.
- Patients must be English or Spanish speaking.
- EXCLUSION CRITERIA:
- Presence of psychotic symptoms or severe psychological distress, which in the judgment of the Principal or Associate Investigator, or consulting psychiatrist would compromise the patient s ability to engage in the intervention or is likely to interfere with the study procedures or results.
- Previously identified cognitive impairment which in the judgment of the Principal or Associate Investigator would compromise the patient s ability to understand the Five Wishes material or is likely to interfere with the study procedures or results.
- Clinically significant, systemic illness (serious infections or significant cardiac, pulmonary, hepatic or other organ dysfunction) which in the judgment of the research team would compromise the patient s ability to tolerate this study
Exclusion
Key Trial Info
Start Date :
January 26 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 25 2014
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01445145
Start Date
January 26 2007
End Date
September 25 2014
Last Update
December 12 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgetown University
Washington D.C., District of Columbia, United States, 20007-2197
2
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892